What are you searching for?

01.04.2020 | Insight

#COVID19: HCPs use Twitter polls for advice and to get a ‘feel’ of the wider practice

By Laura McIntyre

#COVID19: HCPs use Twitter polls for advice and to get a ‘feel’ of the wider practice

Coronavirus has not only disrupted medical practice but brought a sense of uncertainty to it. As real-world data on the impact of the virus keeps emerging, HCPs use public social media to connect with one another seeking advice, assurance and to get a ‘feel’ of the wider practice.

HCPs such as UK cardiologist Mamas Mamas, are utilizing Twitter polls to understand if and how coronavirus might have changed their clinical procedures, encouraging others to share their posts, vote and comment.

US Coronary intervention doctor Sripal Bangalore, created a whole thread of polls for each stage of testing and diagnosis of a patient case.

Michael Griksaitis, in the UK, engaged his pediatric intensive care community around retesting children for coronavirus. Interestingly, in a similar poll from Sripal Bangalore the results were slightly different.

A UK Cardiologist, Vass Vassiliou, also turned to his peers for their opinion on polymerase chain reaction test sensitivity when detecting the virus and asked his colleagues to explain their reasoning by commenting on his post.

What are the real informational needs of your HCP customers? How can you add value and directly support them instead of just adding to the noise? Head onto our website, creation.co/COVID19, to find out more.

CREATION.co has been tracking the online HCP conversation relating to coronavirus since the start of the outbreak and is committed to supporting healthcare stakeholders globally.

View all articles >

Meet the Author

Laura McIntyre

Suggested next


08.02.2022 | Article

Top 50 Pharma Tracker: HCPs get political when discussing Regeneron’s COVID-19 treatment

HCPs get political when discussing Regeneron’s COVID-19 treatment

By Francesca Gan and Chawanzi Chintu

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

11.02.2020 | Article

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals

By Nathan Cripps

View all articles >